ANDA 70232, held by Teva. Propranolol Hydrochloride.
As of Nov 15, 2026, ANDA 70232 (Propranolol Hydrochloride), held by Teva, was first approved by FDA on Oct 7, 1987, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 7, 1987 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Propranolol Hydrochloride10MG ยท tablet;oral | Propranolol Hydrochloride | Discontinued |
| Aug 30, 2001 | Supplement 1Manufacturing | Approved | None posted |
| Oct 7, 1987 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
